About SYNPHA BIOSCIENCES CORP
Synpha Biosciences is a new company developing synthetic phage therapeutics for bacterial diseases using patent-protected technology and a machine learning AI platform. The company is based at the University of Wisconsin-Madison and is currently raising funds.
Development of synthetic phage therapeuticsUse of machine learning AI platformPatent-protected technology for phage therapy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SYNPHA BIOSCIENCES CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.